Canhelp-UriBLAD Bladder Cancer Detection A non-invasive urine test for early detection and recurrence surveillance of bladder cancer .
Bladder cancer is the 10th most common cancer type in the world. There were more than 573,000 new cases of bladder cancer in 20201. Early and accurate diagnosis is critical for bladder cancer patients because of concealment and high recurrence rates2.
Canhelp-UriBLAD test is an 8-gene expression assay combined with artificial intelligence analysis soft ware, which can be used for non-invasive bladder cancer detection in conjunction with other clinical measures.
Canhelp-UriBLAD test has high specificity and sensitivity for all tumors independent of grade, which reach 89.9% accuracy, 82.6% sensitivity, and 95.1% specificity7.
CN